Wang Tien-Hsiang, Lee Chen-Hsen, Tseng Ling-Ming, Liu Ren-Hsieng
Department of Surgery, Taipei-Veterans General Hospital, and National Yang-Ming University, Taipei, Taiwan, ROC.
Endocrine. 2003 Aug;21(3):227-31. doi: 10.1385/ENDO:21:3:227.
The occurrence of thyroid cancer in patients with endstage renal disease is rare. We have had the experience of treating two such patients. The problems, encountered in these patients, were the enlarged parathyroid glands at the time of total thyroidectomy and the treatment of these patients with 131I when the biologic halflife of radioiodine increases after hemodialysis. Both patients were treated by total thyroidectomy and postoperative administration of 131I, either empirically or dosimetrically, and are living and well, 9 yr and 7 yr after operations, respectively.
终末期肾病患者中甲状腺癌的发生较为罕见。我们有治疗两名此类患者的经验。这些患者遇到的问题是在全甲状腺切除时甲状旁腺肿大，以及在血液透析后放射性碘的生物半衰期增加时用131I治疗这些患者。两名患者均接受了全甲状腺切除术，并在术后根据经验或剂量测定法给予131I治疗，分别在术后9年和7年时状况良好。
